Need help finding what you are looking for?
Contact Us
PUBLISHER: Grand View Research | PRODUCT CODE: 1813829
PUBLISHER: Grand View Research | PRODUCT CODE: 1813829
Middle East In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents), By Test Location, By End-use (Hospitals, Laboratory), By Application, By Technology, By Region, And Segment Forecasts, 2025 - 2033
PUBLISHED:
PAGES: 320 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Middle East In Vitro Diagnostics Market Summary
The Middle East in vitro diagnostics market size was estimated at USD 2,093.7 million in 2024 and is projected to reach USD 3,797.5 million by 2033, growing at a CAGR of 7.25% from 2025 to 2033. The market is driven by a combination of rising disease prevalence, expanding healthcare infrastructure, and increased investments in early disease detection.
Chronic diseases such as diabetes, cardiovascular disorders, and cancer are on the rise in the region, prompting governments and healthcare providers to prioritize advanced diagnostic testing to improve patient outcomes. According to the World Health Organization (WHO), cancer incidence in the Middle East is expected to double by 2033, with 9 out of 22 countries in the region lacking optimal operational facilities to manage cancer effectively. This unmet need for early diagnosis and treatment, coupled with economic development in emerging markets like Qatar, is creating substantial opportunities for the IVD market.
The Saudi Arabia in vitro diagnostics market is experiencing robust growth, fueled by the increasing prevalence of both communicable and noncommunicable diseases (NCDs), as well as rising awareness and government initiatives to improve healthcare outcomes. The country faces a growing burden of NCDs, such as cardiovascular diseases (CVDs) and diabetes, largely attributed to sedentary lifestyles. In addition, cancers such as lung, colorectal, stomach, breast, and prostate are major causes of cancer-related deaths. According to ScienceDirect, the prevalence of CVDs in Saudi Arabia is projected to reach 479,500 cases by 2035, while over 31,000 new cancer cases were anticipated to be diagnosed in 2023.
Middle East In Vitro Diagnostics Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the Middle East in vitro diagnostics market report based on products, technology, application, test location, end use, and region.
- Product Outlook (Revenue, USD Million, 2021 - 2033)
- Instruments
- Reagents
- Others
- Technology Outlook (Revenue, USD Million, 2021 - 2033)
- Immunoassay
- Instruments
- Reagents
- Others
- Hematology
- Instruments
- Reagents
- Others
- Clinical Chemistry
- Instruments
- Reagents
- Others
- Molecular Diagnostics
- Instruments
- Reagents
- Others
- Coagulation
- Instruments
- Reagents
- Others
- Microbiology
- Instruments
- Reagents
- Others
- Others
- Instruments
- Reagents
- Others
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- Infectious Diseases
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune Diseases
- Drug Testing
- Other applications
- Test Location Outlook (Revenue, USD Million, 2021 - 2033)
- Point of Care
- Home-care
- Others
- End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Hospitals
- Laboratory
- Home Care
- Others
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- Middle East and Africa (MEA)
- Saudi Arabia
- UAE
- Kuwait
- Qatar
- Oman
Product Code: GVR-4-68040-705-2
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Market Definitions
- 1.2.1. Product
- 1.2.2. Technology
- 1.2.3. Application
- 1.2.4. Test Location
- 1.2.5. End Use
- 1.3. Regional Scope
- 1.4. Estimates and Forecast Timeline
- 1.5. Research Methodology
- 1.6. Information Procurement
- 1.6.1. Purchased Database
- 1.6.2. GVR's Internal Database
- 1.7. Details of primary research
- 1.8. Market Formulation & Validation
- 1.9. Model Details
- 1.9.1. Commodity flow analysis (Model 1)
- 1.9.1.1. Approach 1: Commodity flow approach
- 1.9.2. Volume price analysis (Model 2)
- 1.9.2.1. Approach 2: Volume price analysis
- 1.9.1. Commodity flow analysis (Model 1)
- 1.10. Research Scope and Assumptions
- 1.10.1. List of Secondary Sources
- 1.10.2. List of Primary Sources
- 1.10.3. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Middle East In Vitro Diagnostics Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Drivers Analysis
- 3.2.1.1. Introduction of Technologically Advanced Products
- 3.2.1.2. Increasing Demand for PoC Testing
- 3.2.1.3. Growing Prevalence of Target Diseases
- 3.2.1.4. Increasing External Funding for R&D
- 3.2.2. Market Restraints Analysis
- 3.2.2.1. Presence of Ambiguous Regulatory Framework
- 3.2.2.2. High Capital Investment
- 3.2.2.3. High Prices of Molecular Diagnostic Tests
- 3.2.3. Market Opportunity Analysis
- 3.2.4. Supply Chain Analysis
- 3.2.5. Distribution Channel
- 3.2.5.1. Direct Sales
- 3.2.5.2. Distributors Network
- 3.2.5.3. E-commerce and Online Platforms
- 3.2.5.4. Major Distributors
- 3.2.1. Market Drivers Analysis
- 3.3. Middle East In Vitro Diagnostics Market Analysis Tools
- 3.3.1. Porter's Analysis
- 3.3.1.1. Bargaining power of the suppliers
- 3.3.1.2. Bargaining power of the buyers
- 3.3.1.3. Threats of substitution
- 3.3.1.4. Threats from new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Economic and Social landscape
- 3.3.2.3. Technological landscape
- 3.3.2.4. Legal landscape
- 3.3.1. Porter's Analysis
- 3.4. Reimbursement Overview of IVDs and LDTs
- 3.5. Pricing Analysis
Chapter 4. Middle East In Vitro Diagnostics Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Middle East In Vitro Diagnostics Market: Product Movement Analysis, 2024 & 2033 (USD Million)
- 4.3. Instruments
- 4.3.1. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4. Reagents
- 4.4.1. Reagents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5. Services
- 4.5.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Middle East In Vitro Diagnostics Market: Technology Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Middle East In Vitro Diagnostics Market: Technology Movement Analysis, 2024 & 2033 (USD Million)
- 5.3. Immunoassay
- 5.3.1. Immunoassay Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.3.2. Instruments
- 5.3.2.1. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million) (Volume, Number of Units)
- 5.3.3. Reagents
- 5.3.3.1. Reagents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.3.4. Services
- 5.3.4.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.4. Hematology
- 5.4.1. Hematology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.4.2. Instruments
- 5.4.2.1. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.4.3. Reagents
- 5.4.3.1. Reagents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.4.4. Services
- 5.4.4.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.5. Clinical Chemistry
- 5.5.1. Clinical Chemistry Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.5.2. Instruments
- 5.5.2.1. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.5.3. Reagents
- 5.5.3.1. Reagents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.5.4. Services
- 5.5.4.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.6. Molecular Diagnostics
- 5.6.1. Molecular Diagnostics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.6.2. Instruments
- 5.6.2.1. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.6.3. Reagents
- 5.6.3.1. Reagents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.6.4. Services
- 5.6.4.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.7. Coagulation
- 5.7.1. Coagulation Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.7.2. Instruments
- 5.7.2.1. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.7.3. Reagents
- 5.7.3.1. Reagents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.7.4. Services
- 5.7.4.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.8. Microbiology
- 5.8.1. Microbiology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.8.2. Instruments
- 5.8.2.1. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.8.3. Reagents
- 5.8.3.1. Reagents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.8.4. Services
- 5.8.4.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.9. Others
- 5.9.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.9.2. Instruments
- 5.9.2.1. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.9.3. Reagents
- 5.9.3.1. Reagents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.9.4. Services
- 5.9.4.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Middle East In Vitro Diagnostics Market: Application Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Middle East In Vitro Diagnostics Market: Application Movement Analysis, 2024 & 2033 (USD Million)
- 6.3. Infectious Disease
- 6.3.1. Infectious Disease Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.4. Diabetes
- 6.4.1. Diabetes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5. Oncology/Cancer
- 6.5.1. Oncology/Cancer Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.6. Cardiology
- 6.6.1. Cardiology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.7. Nephrology
- 6.7.1. Nephrology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.8. Autoimmune Diseases
- 6.8.1. Autoimmune Diseases Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.9. Drug Testing
- 6.9.1. Drug Testing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.10. Others
- 6.10.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Middle East In Vitro Diagnostics Market: Test Location Estimates & Trend Analysis
- 7.1. Segment Dashboard
- 7.2. Middle East In Vitro Diagnostics Market: Test Location Movement Analysis, 2024 & 2033 (USD Million)
- 7.3. Point of Care
- 7.3.1. Point of Care Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4. Home-care
- 7.4.1. Home-care Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5. Others
- 7.5.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Middle East In Vitro Diagnostics Market: End Use Estimates & Trend Analysis
- 8.1. Segment Dashboard
- 8.2. Middle East In Vitro Diagnostics Market: End Use Movement Analysis, 2024 & 2033 (USD Million)
- 8.3. Hospitals
- 8.3.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.4. Laboratory
- 8.4.1. Laboratory Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5. Home Care
- 8.5.1. Home Care Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.6. Others
- 8.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 9. Middle East In Vitro Diagnostics Market: Regional Estimates & Trend Analysis
- 9.1. Middle East In Vitro Diagnostics Market Share, By Region, 2024 & 2033 (USD Million)
- 9.2. Middle East and Africa
- 9.2.1. Middle East and Africa Middle East In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.2.2. Saudi Arabia
- 9.2.2.1. Key Country Dynamics
- 9.2.2.2. Regulatory Landscape/Reimbursement Scenario
- 9.2.2.3. Competitive Insights
- 9.2.2.4. Saudi Arabia Middle East In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.2.3. UAE
- 9.2.3.1. Key Country Dynamics
- 9.2.3.2. Regulatory Landscape/Reimbursement Scenario
- 9.2.3.3. Competitive Insights
- 9.2.3.4. UAE Middle East In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.2.4. Qatar
- 9.2.4.1. Key Country Dynamics
- 9.2.4.2. Regulatory Landscape/Reimbursement Scenario
- 9.2.4.3. Competitive Insights
- 9.2.4.4. Qatar Middle East In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.2.5. Kuwait
- 9.2.5.1. Key Country Dynamics
- 9.2.5.2. Regulatory Landscape/Reimbursement Scenario
- 9.2.5.3. Competitive Insights
- 9.2.5.4. Kuwait Middle East In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.2.6. Oman
- 9.2.6.1. Key Country Dynamics
- 9.2.6.2. Regulatory Landscape/Reimbursement Scenario
- 9.2.6.3. Competitive Insights
- 9.2.6.4. Kuwait Middle East In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 10. Competitive Landscape
- 10.1. Recent Developments & Impact Analysis by Key Market Participants
- 10.2. Company Categorization
- 10.3. Company Market Share Analysis, 2024
- 10.4. Company Heat Map Analysis
- 10.5. Strategy Mapping
- 10.5.1. Expansion
- 10.5.2. Mergers & Acquisition
- 10.5.3. Partnerships & Collaborations
- 10.5.4. New Product Launches
- 10.5.5. Research And Development
- 10.6. Company Profiles
- 10.6.1. Abbott
- 10.6.1.1. Participant's Overview
- 10.6.1.2. Financial Performance
- 10.6.1.3. Product Benchmarking
- 10.6.1.4. Recent Developments
- 10.6.2. Bio-Rad Laboratories, Inc
- 10.6.2.1. Participant's Overview
- 10.6.2.2. Financial Performance
- 10.6.2.3. Product Benchmarking
- 10.6.2.4. Recent Developments
- 10.6.3. Siemens Healthineers AG
- 10.6.3.1. Participant's Overview
- 10.6.3.2. Financial Performance
- 10.6.3.3. Product Benchmarking
- 10.6.3.4. Recent Developments
- 10.6.4. BIOMERIEUX
- 10.6.4.1. Participant's Overview
- 10.6.4.2. Financial Performance
- 10.6.4.3. Product Benchmarking
- 10.6.4.4. Recent Developments
- 10.6.5. BD
- 10.6.5.1. Participant's Overview
- 10.6.5.2. Financial Performance
- 10.6.5.3. Product Benchmarking
- 10.6.5.4. Recent Developments
- 10.6.6. QIAGEN
- 10.6.6.1. Participant's Overview
- 10.6.6.2. Financial Performance
- 10.6.6.3. Product Benchmarking
- 10.6.6.4. Recent Developments
- 10.6.7. Quidel Corporation
- 10.6.7.1. Participant's Overview
- 10.6.7.2. Financial Performance
- 10.6.7.3. Product Benchmarking
- 10.6.7.4. Recent Developments
- 10.6.8. F. Hoffmann-La Roche Ltd.
- 10.6.8.1. Participant's Overview
- 10.6.8.2. Financial Performance
- 10.6.8.3. Product Benchmarking
- 10.6.8.4. Recent Developments
- 10.6.9. Danaher
- 10.6.9.1. Participant's Overview
- 10.6.9.2. Financial Performance
- 10.6.9.3. Product Benchmarking
- 10.6.9.4. Recent Developments
- 10.6.10. Randax Laboratories
- 10.6.10.1. Participant's Overview
- 10.6.10.2. Financial Performance
- 10.6.10.3. Product Benchmarking
- 10.6.10.4. Recent Developments
- 10.6.11. Agilent Technologies, Inc.
- 10.6.11.1. Participant's Overview
- 10.6.11.2. Financial Performance
- 10.6.11.3. Product Benchmarking
- 10.6.11.4. Recent Developments
- 10.6.1. Abbott
Product Code: GVR-4-68040-705-2
List of Tables
- Table 1 List of Secondary Sources
- Table 2 List of Abbreviations
- Table 3 Regulatory Framework
- Table 4 MEA Middle East In Vitro Diagnostics Market, By Country, 2021 - 2033 (USD Million)
- Table 5 MEA Middle East In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD Million)
- Table 6 MEA Middle East In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
- Table 7 MEA Middle East In Vitro Diagnostics Market, By Application, 2021 - 2033 (USD Million)
- Table 8 MEA Middle East In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD Million)
- Table 9 MEA Middle East In Vitro Diagnostics Market, By Test Location, 2021 - 2033 (USD Million)
- Table 10 Qatar Middle East In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD Million)
- Table 11 Qatar Middle East In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
- Table 12 Qatar Middle East In Vitro Diagnostics Market, By Application, 2021 - 2033 (USD Million)
- Table 13 Qatar Middle East In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD Million)
- Table 14 UAE Middle East In Vitro Diagnostics Market, By Test Location, 2021 - 2033 (USD Million)
- Table 15 UAE Middle East In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD Million)
- Table 16 UAE Middle East In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
- Table 17 UAE Middle East In Vitro Diagnostics Market, By Application, 2021 - 2033 (USD Million)
- Table 18 UAE Middle East In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD Million)
- Table 19 UAE Middle East In Vitro Diagnostics Market, By Test Location, 2021 - 2033 (USD Million)
- Table 20 Saudi Arabia Middle East In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD Million)
- Table 21 Saudi Arabia Middle East In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
- Table 22 Saudi Arabia Middle East In Vitro Diagnostics Market, By Application, 2021 - 2033 (USD Million)
- Table 23 Saudi Arabia Middle East In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD Million)
- Table 24 Saudi Arabia Middle East In Vitro Diagnostics Market, By Test Location, 2021 - 2033 (USD Million)
- Table 25 Oman Middle East In Vitro Diagnostics Market, By Test Location, 2021 - 2033 (USD Million)
- Table 26 Oman Middle East In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD Million)
- Table 27 Oman Middle East In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
- Table 28 Oman Middle East In Vitro Diagnostics Market, By Application, 2021 - 2033 (USD Million)
- Table 29 Oman Middle East In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD Million)
- Table 30 Oman Middle East In Vitro Diagnostics Market, By Test Location, 2021 - 2033 (USD Million)
- Table 31 Kuwait Middle East In Vitro Diagnostics Market, By Test Location, 2021 - 2033 (USD Million)
- Table 32 Kuwait Middle East In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD Million)
- Table 33 Kuwait Middle East In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
- Table 34 Kuwait Middle East In Vitro Diagnostics Market, By Application, 2021 - 2033 (USD Million)
- Table 35 Kuwait Middle East In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD Million)
- Table 36 Kuwait Middle East In Vitro Diagnostics Market, By Test Location, 2021 - 2033 (USD Million)
List of Figures
- Fig. 1 Middle East In Vitro Diagnostics market segmentation
- Fig. 2 Market research process
- Fig. 3 Data triangulation techniques
- Fig. 4 Primary research pattern
- Fig. 5 Market research approaches
- Fig. 6 Value-chain-based sizing & forecasting
- Fig. 7 QFD modeling for market share assessment
- Fig. 8 Market formulation & validation
- Fig. 9 In vitro diagnostic market snapshot
- Fig. 10 Parent market outlook, 2024
- Fig. 11 In vitro diagnostic market driver impact
- Fig. 12 MEAelderly population
- Fig. 13 New cancer cases by year
- Fig. 14 In vitro diagnostic market restraint impact
- Fig. 15 Market entry strategy
- Fig. 16 SWOT analysis, by factor (political & legal, economic, and technological)
- Fig. 17 Porter's five forces analysis
- Fig. 18 IVD market: Product outlook and key takeaways
- Fig. 19 IVD market: Products movement analysis
- Fig. 20 Instruments market estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 21 Reagents market estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 22 Services market estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 23 IVD market: Technology outlook and key takeaways
- Fig. 24 IVD Market: Technology movement analysis
- Fig. 25 Immunoassay market estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 26 Instruments market for immunoassay estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 27 Reagents market for immunoassay estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 28 Services market for immunoassay estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 29 Hematology market estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 30 Instruments market for hematology estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 31 Reagents market for hematology estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 32 Services market for hematology estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 33 Clinical chemistry market estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 34 Instruments market for clinical chemistry estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 35 Reagents market for clinical chemistry estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 36 Services market for clinical chemistry estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 37 Molecular diagnostics market estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 38 Instruments market for molecular diagnostics estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 39 Reagents market for molecular diagnostics estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 40 Services market for molecular diagnostics estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 41 Coagulation market estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 42 Instruments market for coagulation estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 43 Reagents market for coagulation estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 44 Services market for coagulation estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 45 Microbiology market estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 46 Instruments market for microbiology estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 47 Reagents market for microbiology estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 48 Services market for microbiology estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 49 Others market estimates and forecast, 2021 - 2033 (USD Million)million,
- Fig. 50 Instruments others market estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 51 Reagents others market estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 52 Services market for other technology estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 53 IVD market: Application outlook and key takeaways
- Fig. 54 IVD market: Application movement analysis
- Fig. 55 Infectious diseases market estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 56 Diabetes market estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 57 Oncology market estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 58 Cardiology market estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 59 Nephrology market estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 60 Autoimmune diseases market estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 61 Drug testing market estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 62 Others market estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 63 IVD market: End-use outlook and key takeaways
- Fig. 64 IVD treatment market: End-use movement analysis
- Fig. 65 Hospitals market estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 66 Laboratory market estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 67 Home care market estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 68 Other market estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 69 IVD market: test location outlook and key takeaways
- Fig. 70 IVD treatment market: Test location movement analysis
- Fig. 71 Point-of-care market estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 72 Homecare market estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 73 Others market estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 74 IVD Market: Regional outlook and key takeaways
- Fig. 75 IVD market: Regional movement analysis
- Fig. 76 MEA key country dynamics
- Fig. 77 MEA market estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 78 Qatar key country dynamics
- Fig. 79 Qatar market estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 80 UAE key country dynamics
- Fig. 81 UAE market estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 82 Saudi Arabia key country dynamics
- Fig. 83 Saudi Arabia market estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 84 Oman key country dynamics
- Fig. 85 Oman market estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 86 Kuwait key country dynamics
- Fig. 87 Kuwait market estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 88 Ansoff matrix
- Fig. 89 Competition categorization
- Fig. 90 Company market share analysis, 2024
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.